{"disease":{"id":"inflammatory-acne","name":"inflammatory acne"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03497897","title":"Study to Assess the Efficacy and Safety of LYS006 in Patients With Moderate to Severe Inflammatory Acne","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT05830968","title":"Safety and Efficacy of Radio Frequency for the Treatment of Mild to Severe Inflammatory Acne","phase":"NA","overall_status":"RECRUITING","enrollment_count":42,"lead_sponsor_name":"InMode MD Ltd.","has_results":false},{"nct_id":"NCT06080035","title":"The Effects of Cetyl Tranexamate Mesylate on the Appearance of Acne-Related Hyperpigmentation","phase":"NA","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Integrative Skin Science and Research","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}